Hone approaches NAD+ through a broader membership offering. That creates a different cost structure from a single advertised medication price: the medication and membership can be separate charges, and some conversations with a clinician can cost extra.
We reviewed Hone’s public Basic membership information and NAD+ help resources. The numbers below are published estimates, not a personal quote. This is an editorial document review, not a patient testimonial; CoreAge Rx separately receives featured commercial placement on this site.
Compare the full membership-plus-medication commitment. A broader service may offer useful access, but NAD+ still requires its own clinical discussion and follow-up plan.
Illustrative Basic total: $165 estimated medication + $25 membership, before a $25 one-time onboarding fee and optional consultations.
Build the total from the actual components
Hone’s Basic membership page lists an estimated NAD+ medication cost of $165 per month and a separate $25 monthly membership fee. Adding those produces an illustrative $190 monthly total before other charges. The same page lists a $25 one-time onboarding fee and separately priced optional consultations.
This arithmetic is useful only if Basic is the plan that applies to you. Other membership tiers, a different prescription, or additional services can change the amount. Ask for an itemized quote rather than assuming the medication estimate covers the entire program. Our cost guide explains how to compare a membership service with a bundled offer.
What the membership is meant to provide
The Basic materials describe recurring laboratory testing and access to certain longevity treatments, while medication is billed separately. Optional live consultations have their own purchase terms. Those distinctions matter if your main reason for joining is an ongoing conversation with a clinician rather than access to a medication alone.
Before enrolling, ask which clinical interactions are included, which require a purchase, and who interprets results in your situation. Testing does not automatically answer whether NAD+ treatment is appropriate. A test result should be interpreted in the context of your symptoms and health history, not used as an isolated reason to begin a longevity product.
Questions for people comparing broader care
A membership may be appealing if you want several services organized in one place. It can be less appealing if you only want one assessment and do not expect to use the continuing benefits. Make a list of what you realistically plan to use over the next few months.
Ask whether stopping the NAD+ prescription also stops the membership. Check when cancellation takes effect and whether a pending medication charge is handled separately. Keep a record of both billing streams if there are two. A recurring fee that continues during a medication pause can materially change the value of the program for you.
The injection still needs its own evaluation
A broader health program does not settle the evidence for an individual compounded prescription. NAD+ has an established role in cellular metabolism, but that role is not proof that injecting it improves longevity, memory, or strength. Nor does a membership’s laboratory schedule demonstrate that every potential risk is monitored.
Ask which outcome the clinician expects to evaluate and what would lead to changing or stopping treatment. The evidence guide distinguishes human IV pilot research from evidence about home injections. The route comparison is useful if you are also considering an infusion clinic or nasal product.
Clarify the pharmacy, device, and follow-up
Request the dispensing pharmacy’s name and a way to reach the pharmacist. Confirm the exact preparation, concentration, allowed use period, storage instructions, and supplied device. If a future refill looks different, obtain an explanation before applying old instructions to a new label.
Ask how to reach someone for a side effect between scheduled reviews. A support team that handles membership questions may need to route clinical concerns elsewhere. Have that contact path ready before treatment begins. Our prescription-label guide provides a short checklist to use when a shipment arrives.
Who should compare this model closely
If you value the other included services and understand the separate consultation charges, the membership structure may be worth exploring. If your priority is the lowest ongoing cost for one proposed medication, compare the total over the period you expect to remain enrolled.
The CoreAge Rx review discusses conflicting advertised starting prices, while the Eden review separates its introductory offer from an unconfirmed renewal cost. The AgelessRx review explains why billing every four weeks deserves attention. These differences can matter more than a simple ranked price list.
Related questions before an evaluation.
Review home-injection responsibilities, dosing-label questions, and how to assess results before committing to a program. If you are comparing with a store-bought option, oral supplements have different ingredients, evidence, and costs.
Sources & reading notes
Primary sources checked September 18, 2026. Provider pages describe their own offers; inclusion does not verify a product or its results.
- Hone: Basic membership and medication costs Provider lists $165/month estimated NAD+ cost, $25/month membership, and a $25 onboarding fee. Optional consultation fees are separate.
- FDA: compounding questions and answers Explains that compounded drugs are not FDA-approved.
- FDA: ingredients suitable for sterile compounding Safety notice describing reported reactions and ingredient-quality concerns.
- Grant et al. (2019): NAD+ infusion metabolome pilot Small human IV study; metabolic observations do not prove longevity or everyday benefits.
- Reyna et al. (2026): retrospective IV tolerability pilot Route-specific retrospective tolerability evidence; not proof of effectiveness for home injections.
Educational information, not individualized medical advice. We do not claim medical review or firsthand treatment experience. Read our review standards and commercial disclosure.